JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 44.06%-1.12B | ---- | -251.52%-2B | ---- | 72.43%1.32B | ---- | 70.18%766.01M | ---- | 127.72%450.11M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -304.18%-150.68M | ---- | -48.28%-37.28M | ---- | -6.14%-25.14M | ---- | 14.08%-23.69M | ---- | ---27.57M |
Investment loss (gain) | ---- | ---- | ---- | 3.32%-379K | ---- | ---392K | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 628.13%845K | ---- | ---160K |
Impairment and provisions: | ---- | -32.41%1.65B | ---- | 3,459.51%2.45B | ---- | 737.23%68.73M | ---- | 104.31%8.21M | ---- | 299.01%4.02M |
-Impairment of property, plant and equipment (reversal) | ---- | --25.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | -50.58%142.38M | ---- | --288.13M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -31.15%1.49B | ---- | 3,040.27%2.16B | ---- | 737.23%68.73M | ---- | 104.31%8.21M | ---- | 299.01%4.02M |
Revaluation surplus: | ---- | ---3.8M | ---- | ---- | ---- | ---49.8M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---3.8M | ---- | ---- | ---- | ---49.8M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | -87.78%2.95M | ---- | 2,333.53%24.17M | ---- | -41.93%993K | ---- | 199.02%1.71M | ---- | -270.48%-1.73M |
-Loss (gain) from sale of subsidiary company | ---- | -46.67%1.44M | ---- | --2.7M | ---- | ---- | ---- | --2.46M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -70.45%1.39M | ---- | 773.56%4.69M | ---- | 242.04%537K | ---- | -5.99%157K | ---- | 21.90%167K |
-Loss (gain) from selling other assets | ---- | -99.24%127K | ---- | 3,578.07%16.77M | ---- | 150.44%456K | ---- | 52.27%-904K | ---- | -298.53%-1.89M |
Depreciation and amortization: | ---- | 29.49%87.89M | ---- | 188.71%67.87M | ---- | 60.27%23.51M | ---- | 25.24%14.67M | ---- | 11.38%11.71M |
-Depreciation | ---- | 17.26%53.16M | ---- | 196.58%45.34M | ---- | 24.92%15.29M | ---- | --12.24M | ---- | ---- |
-Amortization of intangible assets | ---- | 50.49%33.75M | ---- | 172.77%22.43M | ---- | 238.21%8.22M | ---- | 115.71%2.43M | ---- | -4.73%1.13M |
Exchange Loss (gain) | ---- | 109.34%2.51M | ---- | -129.58%-26.85M | ---- | 125.19%90.76M | ---- | --40.3M | ---- | ---- |
Special items | ---- | 44.92%-3.95M | ---- | -17.18%-7.16M | ---- | ---6.11M | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | 0.77%468.93M | ---- | -67.31%465.36M | ---- | 76.15%1.42B | ---- | 85.17%808.06M | ---- | 100.66%436.39M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 133.93%1.94M | ---- | 11.22%-5.72M | ---- | 38.25%-6.44M | ---- | -992.15%-10.43M | ---- | 52.42%-955K |
Accounts receivable (increase)decrease | ---- | -105.11%-332.88M | ---- | 90.00%-162.3M | ---- | -91.13%-1.62B | ---- | -124.09%-848.95M | ---- | -151.46%-378.85M |
Accounts payable increase (decrease) | ---- | 202.06%385.21M | ---- | -79.76%127.53M | ---- | 215.06%629.93M | ---- | 41.34%199.94M | ---- | -3.32%141.47M |
Special items for working capital changes | ---- | -108.97%-11.91M | ---- | -12.54%132.83M | ---- | 56.99%151.87M | ---- | 34.90%96.74M | ---- | 25.02%71.71M |
Cash from business operations | -1,042.08%-279.6M | -8.32%511.28M | 84.45%-24.48M | -3.21%557.7M | -121.32%-157.47M | 134.83%576.18M | 761.58%738.45M | -9.05%245.36M | 231.77%85.71M | 0.48%269.76M |
Other taxs | 10.35%-60.2M | 48.24%-106.62M | 60.11%-67.15M | -34.06%-206.01M | -117.35%-168.33M | -24.41%-153.66M | -1.60%-77.45M | -261.84%-123.51M | -156.47%-76.23M | -220.28%-34.14M |
Interest received - operating | -26.75%16.85M | 11.56%46.46M | 23.89%23M | 82.95%41.64M | 5.39%18.57M | 121.12%22.76M | 1,380.34%17.62M | 776.09%10.29M | --1.19M | --1.18M |
Net cash from operations | -370.58%-322.96M | 14.69%451.12M | 77.66%-68.63M | -11.67%393.34M | -145.27%-307.24M | 236.98%445.28M | 6,260.11%678.62M | -44.20%132.14M | 111.26%10.67M | -8.15%236.8M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | 124.20%2.89M | --2.89M | --1.29M | ---- | ---- | ---- | ---- |
Dividend received - investment | 364.30%4.64M | 5,526.40%17.05M | --1M | --303K | ---- | ---- | ---- | ---- | ---- | ---- |
Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---74.43M | ---- | ---- | ---- |
Loan receivable (increase) decrease | --8M | 98.07%-29M | ---- | ---1.5B | ---- | ---- | ---- | 348.16%2.19B | 40.33%413.69M | 136.60%488.04M |
Decrease in deposits (increase) | ---457.3M | -189.73%-220M | ---- | 200.00%245.17M | 134.58%245.17M | ---245.17M | ---709.06M | ---- | ---- | ---- |
Sale of fixed assets | -36.34%1.7M | 796.65%2.94M | 349.08%2.67M | -80.57%328K | 146.89%595K | 859.09%1.69M | 40.94%241K | 27.54%176K | 418.18%171K | -29.23%138K |
Purchase of fixed assets | 4.47%-21.57M | 25.02%-62.03M | 91.39%-22.58M | 43.67%-82.72M | -764.43%-262.36M | -1,110.56%-146.85M | -1,078.68%-30.35M | -35.45%-12.13M | -2.30%-2.58M | 20.24%-8.96M |
Selling intangible assets | 3,766.46%43.69M | -84.08%2.24M | -91.73%1.13M | 105.86%14.05M | 101.47%13.66M | -53.06%6.83M | -38.56%6.78M | 6.01%14.54M | 24.97%11.04M | 3.47%13.72M |
Purchase of intangible assets | 14.38%-959K | -20.29%-13.87M | 69.12%-1.12M | -2.63%-11.53M | 34.85%-3.63M | -51.78%-11.24M | -160.26%-5.57M | -169.16%-7.4M | -704.14%-2.14M | -197.30%-2.75M |
Sale of subsidiaries | -1.72%-4.69M | -460.61%-9.28M | -278.94%-4.61M | --2.57M | --2.57M | ---- | ---- | --58.44M | --8.03M | ---- |
Acquisition of subsidiaries | ---- | 32.83%-91.54M | 65.49%-45.73M | 58.90%-136.28M | -88.15%-132.52M | ---331.63M | ---70.43M | ---- | ---- | ---- |
Recovery of cash from investments | 1,195.40%148.97M | 2,930.08%11.48M | --11.5M | -99.49%379K | ---- | --74.69M | --14.35M | ---- | ---- | ---- |
Cash on investment | -829.23%-328.15M | 168.38%166.71M | 65.26%-35.31M | 62.40%-243.8M | -1,136.94%-101.64M | -5,497.70%-648.44M | -115.73%-8.22M | ---11.58M | ---3.81M | ---- |
Other items in the investment business | -3,430.33%-114.4M | 4.93%-44.38M | --3.44M | -20,484.28%-46.68M | ---- | --229K | ---- | ---- | ---- | ---- |
Net cash from investment operations | -703.53%-720.06M | 84.64%-269.67M | 61.91%-89.61M | -35.17%-1.76B | 73.17%-235.26M | -158.25%-1.3B | -306.57%-876.69M | 354.77%2.23B | 41.06%424.4M | 137.08%490.19M |
Net cash before financing | -559.13%-1.04B | 113.32%181.44M | 70.83%-158.24M | -59.61%-1.36B | -173.90%-542.5M | -136.14%-853.32M | -145.52%-198.06M | 224.82%2.36B | 111.09%435.07M | 168.32%726.99M |
Cash flow from financing activities | ||||||||||
Refund | ---- | ---- | ---- | ---2.41M | ---2.41M | ---- | ---- | -266.00%-1.83B | -42.55%-335M | -42.86%-500M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.79B | ---- | ---- |
Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 46.22%-88.86M | 24.24%-66.21M | -5.03%-165.22M |
Dividends paid - financing | -79.13%-6.76M | 97.73%-9.82M | 99.06%-3.78M | -29.74%-431.91M | -22.71%-401.15M | -11,671.68%-332.9M | ---326.9M | 98.07%-2.83M | ---- | -51.58%-146.65M |
Absorb investment income | -93.25%80K | -89.69%1.48M | -76.39%1.19M | 0.46%14.39M | 117.16%5.02M | -97.03%14.32M | -99.52%2.31M | 12,299.87%481.86M | 53,844.04%480.1M | 22.97%3.89M |
Issuance expenses and redemption of securities expenses | ---- | -88.27%-1.28M | ---- | 90.19%-682K | ---536K | 94.70%-6.95M | ---- | ---131.13M | ---3.02M | ---- |
Other items of the financing business | -21.51%-53.12M | -336.78%-313.91M | 27.58%-43.71M | 89.04%-71.87M | -2,995.59%-60.36M | -4,142.69%-655.88M | ---1.95M | ---15.46M | ---- | ---- |
Net cash from financing operations | -28.54%-77.5M | 33.80%-343.18M | 87.20%-60.29M | 47.65%-518.38M | -43.64%-471.03M | -123.57%-990.25M | -537.09%-327.94M | 618.51%4.2B | 115.99%75.03M | -181.22%-810.15M |
Effect of rate | -56.62%95K | -108.99%-2.51M | -99.20%219K | 130.83%27.88M | 146.40%27.49M | -124.38%-90.43M | ---59.24M | ---40.3M | ---- | ---- |
Net Cash | -412.74%-1.12B | 91.40%-161.73M | 78.44%-218.53M | -2.00%-1.88B | -92.69%-1.01B | -128.09%-1.84B | -203.12%-526M | 7,991.49%6.56B | 293.87%510.1M | -24.81%-83.15M |
Begining period cash | -5.35%2.91B | -37.63%3.07B | -37.63%3.07B | -28.21%4.92B | -28.21%4.92B | 1,949.76%6.86B | 1,958.02%6.86B | -19.65%334.49M | -19.97%333.15M | -13.80%416.3M |
Cash at the end | -37.40%1.79B | -5.35%2.91B | -27.56%2.85B | -37.63%3.07B | -37.23%3.94B | -28.21%4.92B | 643.68%6.27B | 1,958.02%6.86B | 450.47%843.24M | -19.97%333.15M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.